FI953314A - Biohajoavien polyesterien ja bioaktiivisten polypeptidien ionisia molekyylijonjugaatteja - Google Patents
Biohajoavien polyesterien ja bioaktiivisten polypeptidien ionisia molekyylijonjugaatteja Download PDFInfo
- Publication number
- FI953314A FI953314A FI953314A FI953314A FI953314A FI 953314 A FI953314 A FI 953314A FI 953314 A FI953314 A FI 953314A FI 953314 A FI953314 A FI 953314A FI 953314 A FI953314 A FI 953314A
- Authority
- FI
- Finland
- Prior art keywords
- biodegradable polyesters
- molecular conjugates
- bioactive polypeptides
- ionic molecular
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicinal Preparation (AREA)
- Biological Depolymerization Polymers (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE930005 | 1993-01-06 | ||
| IE930005 | 1993-01-06 | ||
| US9400148 | 1994-01-05 | ||
| PCT/US1994/000148 WO1994015587A2 (en) | 1993-01-06 | 1994-01-05 | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| CNB941085236A CN1163260C (zh) | 1993-01-06 | 1994-07-20 | 可生物降解聚酯和生物活性多肽的离子性分子轭合物 |
| CN94108523 | 1994-07-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI953314A0 FI953314A0 (fi) | 1995-07-05 |
| FI953314A true FI953314A (fi) | 1995-07-05 |
| FI114898B FI114898B (fi) | 2005-01-31 |
Family
ID=37075859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI953314A FI114898B (fi) | 1993-01-06 | 1995-07-05 | Menetelmä biohajoavien polyesterien ja bioaktiivisten polypeptidien ionisien molekyylikonjugaattien valmistamiseksi |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0678018B1 (fi) |
| JP (1) | JPH08505395A (fi) |
| CN (1) | CN1163260C (fi) |
| AT (1) | ATE236655T1 (fi) |
| AU (1) | AU680650B2 (fi) |
| CA (1) | CA2150574A1 (fi) |
| CZ (2) | CZ293378B6 (fi) |
| DE (1) | DE69432459T2 (fi) |
| DK (1) | DK0678018T3 (fi) |
| ES (1) | ES2196023T3 (fi) |
| FI (1) | FI114898B (fi) |
| HU (1) | HU220137B (fi) |
| NZ (1) | NZ261250A (fi) |
| PL (1) | PL174772B1 (fi) |
| PT (1) | PT678018E (fi) |
| RU (2) | RU2185393C2 (fi) |
| SG (1) | SG47043A1 (fi) |
| SK (1) | SK74495A3 (fi) |
| WO (1) | WO1994015587A2 (fi) |
| ZA (1) | ZA9477B (fi) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221958B1 (en) | 1993-01-06 | 2001-04-24 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| US6413539B1 (en) * | 1996-10-31 | 2002-07-02 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
| US5955574A (en) | 1995-07-13 | 1999-09-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. | Analogs of parathyroid hormone |
| HUP0000732A3 (en) * | 1996-04-23 | 2000-11-28 | Ipsen Mfg Ireland Ltd | Acidic polylactic polymers |
| IE960308A1 (en) * | 1996-04-23 | 1997-11-05 | Kinerton Ltd | Sustained release ionic conjugate |
| AU750739B2 (en) * | 1996-04-23 | 2002-07-25 | Ipsen Manufacturing Ireland Limited | Methods for preparing biodegradable polyesters and derivatives thereof |
| US6264970B1 (en) | 1996-06-26 | 2001-07-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| AU779930B2 (en) * | 1996-12-11 | 2005-02-17 | Praecis Pharmaceuticals Incorporated | Pharmaceutical formulations for sustained drug delivery |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| TW577759B (en) * | 1997-04-18 | 2004-03-01 | Ipsen Pharma Biotech | Sustained release compositions in the form of microcapsules or implants and the process for their preparation |
| US6867181B1 (en) | 1997-06-02 | 2005-03-15 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| US7109166B1 (en) | 1999-08-18 | 2006-09-19 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Sustained release formulation of a peptide |
| ES2209948T3 (es) * | 1999-08-18 | 2004-07-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Formulacion de un peptico de liberacion sostenida. |
| EP1348444B1 (en) * | 1999-08-18 | 2006-04-12 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Sustained release formulation of a peptide complexed with a polymer |
| IES990700A2 (en) * | 1999-08-18 | 2001-08-22 | Kinerton Ltd | Process to make a sustained release formulation |
| EP1272459B1 (en) | 2000-03-31 | 2007-06-27 | Trustees Of Tufts College | 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| KR100452752B1 (ko) * | 2000-04-18 | 2004-10-12 | 주식회사 펩트론 | 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제 |
| US20020176841A1 (en) * | 2001-03-19 | 2002-11-28 | Praecis Pharmaceuticals Inc. | Pharmaceutical formulations for sustained release |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| MXPA05004721A (es) * | 2002-10-31 | 2005-08-03 | Pfizer Prod Inc | Conjugados ionicos polimericos solidos y semisolidos. |
| PT2218448E (pt) | 2002-12-13 | 2016-01-26 | Durect Corp | Sistema oral de entrega de fármaco que compreende materiais transportadores líquidos de alta viscosidade |
| US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| US7186692B2 (en) | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| US7229966B2 (en) | 2002-12-17 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| BR0316685A (pt) | 2002-12-17 | 2005-11-01 | Nastech Pharm Co | Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| SI2246360T1 (sl) | 2003-01-28 | 2012-10-30 | Ironwood Pharmaceuticals Inc | Sestavki za zdravljenje gastrointestinalnih motenj |
| WO2004103390A2 (en) | 2003-05-15 | 2004-12-02 | Trustees Of Tufts College | Stable analogs of peptide and polypeptide therapeutics |
| CN105820160B (zh) | 2003-11-05 | 2019-02-12 | 萨可德生物科学公司 | 细胞粘着调节剂 |
| SI2415484T1 (sl) | 2004-09-17 | 2014-10-30 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
| EP1871796A4 (en) | 2005-04-20 | 2009-01-14 | Auckland Uniservices Ltd | VESICULINE |
| JP5794721B2 (ja) | 2005-05-17 | 2015-10-14 | サーコード バイオサイエンス インコーポレイテッド | 眼障害の治療のための組成物および方法 |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| AU2006287562B2 (en) | 2005-09-08 | 2012-05-10 | Trustees Of Tufts College | Stabilized GLP-1 analogs |
| CN103251933A (zh) | 2005-09-29 | 2013-08-21 | 益普生制药股份有限公司 | 用于刺激胃肠运动性的组合物和方法 |
| WO2007139589A1 (en) | 2006-05-26 | 2007-12-06 | Bristol-Myers Squibb Company | Sustained release glp-1 receptor modulators |
| PT2117521E (pt) | 2006-11-03 | 2012-09-10 | Durect Corp | Sistemas de administração transdérmica que compreendem bupivacaína |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| SI2170390T1 (sl) | 2007-06-14 | 2019-02-28 | Biogen Ma Inc. | Oblike protitelesa natalizumab |
| TW200916113A (en) | 2007-08-08 | 2009-04-16 | Sod Conseils Rech Applic | Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue |
| ES2830024T3 (es) | 2007-10-19 | 2021-06-02 | Novartis Ag | Composiciones y métodos para el tratamiento del edema macular |
| EP3326621A1 (en) | 2007-12-06 | 2018-05-30 | Durect Corporation | Oral pharmaceutical dosage forms |
| US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| EP2362767B1 (en) | 2008-10-29 | 2017-12-06 | Ablynx N.V. | Formulations of single domain antigen binding molecules |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| KR101224004B1 (ko) | 2009-12-29 | 2013-01-22 | 주식회사 삼양바이오팜 | 단백질, 폴리펩타이드 또는 펩타이드 약물 전달용 고분자 및 그 제조방법, 및 단백질, 폴리펩타이드 또는 펩타이드 약물의 서방형 조성물 및 그 제조 방법 |
| AU2011277983C1 (en) | 2010-07-16 | 2016-09-29 | Ablynx Nv | Modified single domain antigen binding molecules and uses thereof |
| WO2012028496A1 (de) * | 2010-08-31 | 2012-03-08 | Basf Se | Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung |
| BRPI1003424A2 (pt) * | 2010-09-08 | 2013-01-08 | Univ Rio De Janeiro | sistema polimÉtrico de confinamento de amilina humana e anÁlogos agonistas, processo e uso; processo de avaliaÇço funcional de amilina liberada |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| ES2587837T3 (es) | 2010-10-01 | 2016-10-27 | Biogen Ma Inc. | Interferón-beta para su uso como monoterapia o en combinación con otras terapias contra el cáncer |
| EP2705013B1 (en) | 2011-05-04 | 2016-03-30 | Balance Therapeutics, Inc. | Pentylenetetrazole derivatives |
| US20140199385A1 (en) * | 2011-07-22 | 2014-07-17 | Innocore Technologies B.V. | Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds |
| WO2014018748A1 (en) | 2012-07-25 | 2014-01-30 | Sarcode Bioscience Inc. | Lfa-1 inhibitor and polymorph thereof |
| WO2014131024A2 (en) | 2013-02-25 | 2014-08-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| US9555113B2 (en) | 2013-03-15 | 2017-01-31 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2918787A1 (en) | 2013-06-13 | 2014-12-18 | George Tachas | Combination therapy |
| CN106061494A (zh) | 2013-10-10 | 2016-10-26 | 辛纳吉制药公司 | 可用于治疗阿片样物质诱导的功能障碍的鸟苷酸环化酶的激动剂 |
| US9181427B2 (en) * | 2013-12-11 | 2015-11-10 | Ethicon, Inc. | Absorbable bimodal polymeric blend compositions, processing methods, and medical devices |
| CN107075134B (zh) * | 2014-11-14 | 2021-03-09 | 赢创运营有限公司 | 制备微粒形式的生物可再吸收聚酯的方法 |
| EP3402804A1 (en) | 2016-01-11 | 2018-11-21 | Synergy Pharmaceuticals Inc. | Formulations and methods for treating ulcerative colitis |
| TR201702016A2 (tr) * | 2017-02-10 | 2018-08-27 | Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak | Düşük mali̇yetli̇ yüksek moleküler ağirlikli ve yüksek çözünürlüğe sahi̇p poli̇gli̇koli̇k asi̇t sentezi̇ |
| CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356166A (en) * | 1978-12-08 | 1982-10-26 | University Of Utah | Time-release chemical delivery system |
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4609707A (en) * | 1983-11-10 | 1986-09-02 | Genetic Systems Corporation | Synthesis of polymers containing integral antibodies |
| US5071909A (en) * | 1989-07-26 | 1991-12-10 | Millipore Corporation | Immobilization of proteins and peptides on insoluble supports |
| US5162505A (en) * | 1989-09-19 | 1992-11-10 | Centocor | Proteins modified with positively charged carriers and compositions prepared therefrom |
| CA2046830C (en) * | 1990-07-19 | 1999-12-14 | Patrick P. Deluca | Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer |
| GB9310030D0 (en) * | 1993-05-15 | 1993-06-30 | Scras | Dry processed particles and process for the preparation of the same |
-
1994
- 1994-01-05 RU RU99122608/04A patent/RU2185393C2/ru not_active IP Right Cessation
- 1994-01-05 EP EP94906037A patent/EP0678018B1/en not_active Expired - Lifetime
- 1994-01-05 SK SK744-95A patent/SK74495A3/sk unknown
- 1994-01-05 DK DK94906037T patent/DK0678018T3/da active
- 1994-01-05 JP JP6516182A patent/JPH08505395A/ja active Pending
- 1994-01-05 CZ CZ19951734A patent/CZ293378B6/cs not_active IP Right Cessation
- 1994-01-05 DE DE69432459T patent/DE69432459T2/de not_active Expired - Fee Related
- 1994-01-05 AU AU59921/94A patent/AU680650B2/en not_active Ceased
- 1994-01-05 RU RU95118395/14A patent/RU2146128C1/ru not_active IP Right Cessation
- 1994-01-05 ES ES94906037T patent/ES2196023T3/es not_active Expired - Lifetime
- 1994-01-05 CA CA002150574A patent/CA2150574A1/en not_active Abandoned
- 1994-01-05 SG SG1996004005A patent/SG47043A1/en unknown
- 1994-01-05 HU HU9502029A patent/HU220137B/hu not_active IP Right Cessation
- 1994-01-05 CZ CZ20002050A patent/CZ293425B6/cs not_active IP Right Cessation
- 1994-01-05 NZ NZ261250A patent/NZ261250A/xx unknown
- 1994-01-05 PL PL94309776A patent/PL174772B1/pl not_active IP Right Cessation
- 1994-01-05 PT PT94906037T patent/PT678018E/pt unknown
- 1994-01-05 WO PCT/US1994/000148 patent/WO1994015587A2/en active IP Right Grant
- 1994-01-05 AT AT94906037T patent/ATE236655T1/de not_active IP Right Cessation
- 1994-01-06 ZA ZA9477A patent/ZA9477B/xx unknown
- 1994-07-20 CN CNB941085236A patent/CN1163260C/zh not_active Expired - Fee Related
-
1995
- 1995-07-05 FI FI953314A patent/FI114898B/fi active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| FI114898B (fi) | 2005-01-31 |
| AU680650B2 (en) | 1997-08-07 |
| JPH08505395A (ja) | 1996-06-11 |
| HU9502029D0 (en) | 1995-09-28 |
| HU220137B (hu) | 2001-11-28 |
| RU2146128C1 (ru) | 2000-03-10 |
| DE69432459D1 (de) | 2003-05-15 |
| WO1994015587A3 (en) | 1994-09-01 |
| HUT73188A (en) | 1996-06-28 |
| FI953314A0 (fi) | 1995-07-05 |
| AU5992194A (en) | 1994-08-15 |
| CZ293425B6 (cs) | 2004-04-14 |
| PT678018E (pt) | 2003-08-29 |
| EP0678018A4 (en) | 1998-09-09 |
| CZ293378B6 (cs) | 2004-04-14 |
| RU2185393C2 (ru) | 2002-07-20 |
| PL174772B1 (pl) | 1998-09-30 |
| WO1994015587A2 (en) | 1994-07-21 |
| PL309776A1 (en) | 1995-11-13 |
| EP0678018B1 (en) | 2003-04-09 |
| DK0678018T3 (da) | 2003-04-28 |
| ZA9477B (en) | 1994-08-11 |
| NZ261250A (en) | 1997-08-22 |
| ES2196023T3 (es) | 2003-12-16 |
| ATE236655T1 (de) | 2003-04-15 |
| SK74495A3 (en) | 1997-01-08 |
| EP0678018A1 (en) | 1995-10-25 |
| CA2150574A1 (en) | 1994-07-21 |
| CN1115252A (zh) | 1996-01-24 |
| CN1163260C (zh) | 2004-08-25 |
| SG47043A1 (en) | 1998-03-20 |
| CZ173495A3 (en) | 1996-01-17 |
| DE69432459T2 (de) | 2003-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI953314A0 (fi) | Biohajoavien polyesterien ja bioaktiivisten polypeptidien ionisia molekyylijonjugaatteja | |
| EP1695718A3 (en) | Biodegradable polyester and Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides | |
| BR9305660A (pt) | Filmes de polímero lactideo de fusao estável e processos para fabricaçao dos mesmos | |
| ES2082507T3 (es) | Composiciones de aerosol presurizado. | |
| DE69417252D1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
| PL323735A1 (en) | Ionic molecular conjugates of n-acylated derivatives of poly92-amino-2-dezoxy-d-glucose) and polypeptides | |
| FR2733427B1 (fr) | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique | |
| FR2471394B1 (fi) | ||
| ES2193272T3 (es) | Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen. | |
| ITMI930182A0 (it) | Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive | |
| ITMI930582A0 (it) | Composizione farmeceutiche ad attivita' analgesica | |
| ES2196187T3 (es) | Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen. | |
| ITMI931325A1 (it) | Composizione farmaceutica ad attivita' analgesica | |
| DE69227276D1 (de) | Konjugate von Calcitonin und Polyethylenglycol | |
| DE69117085D1 (de) | Nylon-6 modifiziert mit Polyethylenglykoldiaminen von niedrigem Molekulargewicht | |
| IL175808A0 (en) | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides | |
| IT1227892B (it) | Composizioni farmaceutiche ad attivita' antidepressiva e ansiolitica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 114898 Country of ref document: FI |
|
| PC | Transfer of assignment of patent |
Owner name: IPSEN MANUFACTURING IRELAND LIMITED |